explore -WSS

explore

author：focus 2025-09-14 22:00:54 - browse：9172

When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozempic? And how do you edit a chicken?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.

For more on what we cover, here’s the news on Mirati; here’s more on biotech venture capital; here’s the latest on Alnylam Pharmaceuticals; here’s more on NASH; here’s the story on xenotransplantation; here’s more on genome-edited chickens; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： What does generative AI mean for health care? We asked experts
Next article： UCB departs biotech trade group BIO

knowledge

hotspot

WSS

JPM: CVS says Medicare Advantage patients are impacting profits

3 medical device trends to watch in 2024

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

AdventHealth escalates lawsuit against insurance vendor Multiplan

entertainment

explore

explore

Duchenne breakthrough therapy leaves behind pioneering families

How a scoliosis diagnosis changed the life of one young dancer

Sports medicine is finally prioritizing gender equality

Goldman Sachs launches $650M fund for life science investments

After affirmative action ruling, medical educators look to 'holistic review'

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

BioMarin wins approval for gene therapy to treat hemophilia A

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The FDA must approve intranasal treatments for anaphylaxis

entertainment

GSK Flovent asthma inhalers replaced by authorized generics

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

U.K. sequencing study surfaces new findings about tumor DNA

3 trends to watch in health tech's hiring outlook for 2024

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Boeing's 1st astronaut flight bumped into next year, more repairs needed

hotspot

knowledge

hotspot

leisure time